Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Clin Microbiol ; 60(1): e0160721, 2022 01 19.
Artigo em Inglês | MEDLINE | ID: mdl-34669454

RESUMO

Magnusiomyces and Geotrichum species are ascomycetous yeasts that can cause potentially life-threatening invasive fungal infections commonly referred to as geotrichosis. In this study, we aimed to estimate the incidence and mortality of these infections in a German tertiary care center. Furthermore, we evaluated the suitability of the fungal biomarkers galactomannan (GM) and ß-1,3-d-glucan (BDG), which are both recommended as surrogate markers for Magnusiomyces capitatus infection by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the European Confederation of Medical Mycology (ECMM) joint clinical guidelines for the diagnosis and management of rare invasive yeast infections for detection of invasive geotrichosis. Cases meeting the inclusion criteria for invasive Magnusiomyces/Geotrichum infection were retrospectively identified. Serum samples and culture supernatants were analyzed with two commercially available fungal antigen tests (Platelia Aspergillus Ag EIA and Wako ß-glucan test). For a control cohort, outpatient samples sent for lues testing were included. Thirty-eight cases of Magnusiomyces/Geotrichum infection were identified over an 11-year observation period. In the majority of cases, the fungus was isolated from intra-abdominal specimens of patients with a history of abdominal surgery/procedures (n = 32). All cases of fungemia occurred exclusively in haemato-oncologic patients (n = 14). Thirty-day survival was 42% in the fungemia and 43% in the intra-abdominal geotrichosis group. Serum samples were available for 23 patients (14 bloodstream and nine intra-abdominal infections). While BDG sensitivity was 65%, none of the sera was GM positive. This finding was supported by in vitro experiments analyzing fungal culture supernatants: M. capitatus secretes significant amounts of BDG but not GM. Specificity was 96% for BDG and 100% for GM. Magnusiomyces and Geotrichum infections are not limited to haemato-oncologic patients. Contrasting the current ESCMID/ECMM recommendation, our results indicate that GM is no suitable biomarker for the diagnosis of Magnusiomyces infection. Contrarily, BDG sensitivity is comparable to that of candidemia.


Assuntos
Geotricose , Geotrichum , Infecções Fúngicas Invasivas , Mananas , Proteoglicanas , Saccharomycetales , beta-Glucanas , Biomarcadores/sangue , Galactose/análogos & derivados , Geotricose/sangue , Geotricose/diagnóstico , Geotrichum/isolamento & purificação , Humanos , Infecções Fúngicas Invasivas/sangue , Infecções Fúngicas Invasivas/diagnóstico , Mananas/sangue , Proteoglicanas/sangue , Estudos Retrospectivos , Saccharomycetales/isolamento & purificação , Sensibilidade e Especificidade , beta-Glucanas/sangue
2.
J Mycol Med ; 28(2): 387-389, 2018 Jun.
Artigo em Francês | MEDLINE | ID: mdl-29709266

RESUMO

We are reporting the case of an 82-year-old Yemeni patient, renal transplant recipient who was admitted to our institution and who subsequently developed disseminated infection with Saprochaete capitata. This pathogenic fungus is rarely reported in patients with solid organ trans-plants. Saprochaete capitata is an emerging fungal pathogen, ubiquitously spread in the environment. This is the second case to our knowledge of infection with Saprochaete capitata in a renal transplant patient. Our patient was treated for multiple nosocomial infections with prolonged antibiotic courses. He succumbed to the infection with Saprochaete capitate after several weeks spent in the intensive care unit.


Assuntos
Infecção Hospitalar/microbiologia , Geotricose/microbiologia , Geotrichum/isolamento & purificação , Transplante de Rim/efeitos adversos , Idoso de 80 Anos ou mais , Antifúngicos/uso terapêutico , Infecção Hospitalar/tratamento farmacológico , Equinocandinas/uso terapêutico , Evolução Fatal , Fungemia/tratamento farmacológico , Fungemia/microbiologia , Geotricose/sangue , Geotricose/tratamento farmacológico , Geotrichum/patogenicidade , Humanos , Unidades de Terapia Intensiva , Masculino , Transplantados
3.
Mycoses ; 59(9): 594-601, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27061932

RESUMO

Invasive fungal infections, usually Aspergillus and Candida, represent a major cause of morbidity and mortality in patients with malignant haematological diseases, but in the last years rare fungal infections have more frequently been reported. Here, we report the clinical history of three patients affected with haematological malignancies who developed an infection caused by Geotrichum (G.) clavatum. Two out of three patients were affected by acute myeloid leukaemia (AML), and one by mantle cell lymphoma (MCL). All patients received cytarabine-based chemotherapeutic regimens and developed G. clavatum infection within 3 weeks from therapy initiation. In all cases, G. clavatum was isolated from central venous catheter and peripheral blood cultures. In vitro susceptibility test confirmed an intrinsic resistance to echinocandins and, in all cases, visceral localisations (spleen, liver and lung) were documented by total body computed tomography (CT) scan. A prolonged antifungal therapy with high doses liposomal amphotericin-B was necessary to obtain fever resolution. Only the patient with MCL died while the other two AML recovered, and one of them after received an allogeneic stem cell transplantation. We consecutively reviewed all published cases of infection caused by G. clavatum. Our experience and literature review indicate that G. clavatum can cause invasive infection in haematological patients, mainly in those with acute leukaemia.


Assuntos
Geotricose/complicações , Neoplasias Hematológicas/complicações , Infecções Fúngicas Invasivas/complicações , Adulto , Anfotericina B/uso terapêutico , Antifúngicos/uso terapêutico , Cateteres Venosos Centrais/microbiologia , Farmacorresistência Fúngica , Equinocandinas/uso terapêutico , Evolução Fatal , Feminino , Geotricose/sangue , Geotricose/epidemiologia , Geotricose/microbiologia , Geotrichum/efeitos dos fármacos , Neoplasias Hematológicas/epidemiologia , Transplante de Células-Tronco Hematopoéticas , Humanos , Infecções Fúngicas Invasivas/diagnóstico por imagem , Infecções Fúngicas Invasivas/epidemiologia , Infecções Fúngicas Invasivas/microbiologia , Itália , Leucemia Mieloide Aguda/complicações , Leucemia Mieloide Aguda/tratamento farmacológico , Leucemia Mieloide Aguda/microbiologia , Fígado/diagnóstico por imagem , Fígado/microbiologia , Pulmão/diagnóstico por imagem , Pulmão/microbiologia , Linfoma de Célula do Manto/complicações , Linfoma de Célula do Manto/tratamento farmacológico , Linfoma de Célula do Manto/microbiologia , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Baço/diagnóstico por imagem , Baço/microbiologia , Tomografia Computadorizada por Raios X , Adulto Jovem
4.
Med J Malaysia ; 49(4): 424-6, 1994 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7674982

RESUMO

Intensive chemotherapy has prolonged survival in cancer patients. Unfortunately it has also predisposed them to unusual infections because of their immunocompromised state. We report a case of fungal septicaemia caused by Geotrichum candidum, an imperfect yeast of low virulence in a young girl with acute lymphoblastic leukaemia. It was successfully treated with amphotericin B. The morphological characteristics of this fungus leading to its identification are described.


Assuntos
Geotricose/sangue , Geotricose/microbiologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Anfotericina B/uso terapêutico , Antineoplásicos/efeitos adversos , Antineoplásicos/uso terapêutico , Pré-Escolar , Feminino , Fungemia/tratamento farmacológico , Geotricose/etiologia , Humanos , Hospedeiro Imunocomprometido
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA